Modus Therapeutics Holding AB
556851-9523ActiveSwedish biotech developing sevuparin for severe inflammatory conditions.
Biotechnology Companymodustx.com
Yleiskatsaus
- 1–4
- Työntekijät
- 500–749t SEK
- Liikevaihto
- 2011
- Perustettu
Kuvaus
Modus Therapeutics is a Swedish biotechnology company focused on developing novel treatments for severe medical conditions. Their primary focus is the development of their proprietary polysaccharide, sevuparin. Sevuparin is being investigated as a potential therapeutic agent for several high unmet m...
Tunnisteet
B2BHolding CompanyTechnologyPharmaceuticals
Avainsanat
Anemia